Safety & PK of SRT2104 in healthy elderly subjects with 28 day dosing

• Research type

  Research Study

• Full title

  A Randomized, Placebo-controlled, Double-blind Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 days Protocol Number - SRT-2104-007

• IRAS ID

  23145

• Eudract number

  2009-011918-21

• ISRCTN Number

  N/A

• Research summary

  N/A

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  09/H0505/96

• Date of REC Opinion

  4 Sep 2009

• REC opinion

  Further Information Favourable Opinion